At a glance
ClinicalIndex Comparison RecordN/ACompleted· 147 enrolled
Drug / intervention
Rifampicin +4 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Fermented Soybean Supplementation on the Body Weight and Physical Function of Tuberculosis Patients With Standard Therapy in Indonesia
In Brief
A clinical study evaluating Rifampicin, Isoniazid, and 3 other interventions for Pulmonary Tuberculosis and 2 related conditions. Completed, enrolled 147 participants.
Detailed Summary
Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Tuberculosis, Body Weight Changes, Motor Activity
Countries--
CollaboratorsIndonesian Directorate General of Higher Education
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
Primary CompletionFeb 2015
First PostedSep 2015
TodayJul 2026
First PostedSep 18, 2015
Enrollment StartNov 1, 2013
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.8 years ago
Interventions
Rifampicindrug
Isoniaziddrug
Pyrazinamidedrug
Ethambutoldrug
Fermented soybeandietary